Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

DARA (Including Video), CLNO, CYN, GABC, ADEP - Stock Report! April 10th 2011

|Includes:ADEP, City National Corporation (CYN), GABC


DARA BioSciences Files 2010 Annual Report and Issues Overview!

DARA BioSciences Initiates a Phase Ib Clinical Study of DB959 for the Treatment of Type 2 Diabetes.

DARA BioSciences, Inc. (Nasdaq:DARA) a clinical biopharmaceutical drug development company, highlights a number of achievements disclosed in the Company's 2010 annual report that was filed with the Securities & Exchange Commission (SEC) on March 25, 2011 and provides an overview. For the year ending December 31, 2010, the Company received approximately $8.4 million in cash and funding commitments to continue the clinical development of its two leading drug candidates that have the potential to help people with neuropathic pain and those with diabetes. As a result of the capital raised during 2010, the Company believes it has sufficient cash to achieve the next series of key milestones during 2011.

DARA's two leading drug candidates have been successfully studied in clinical trials, and DARA is preparing for additional clinical studies during the first half 2011. Selected 2010 highlights include:

Read more at:

Cleantech Transit Inc. ("Cleantech") (OTCBB:CLNO) was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. The Company has expanded its focus to invest directly in specific green projects that can maximize shareholder value. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech has selected to invest in Phoenix Energy ( This project can generate shareholder returns as well benefit the Company's manufacturing clients worldwide.

CLNO has announced that funding to be provided to Phoenix Energy for the commercialization of a 500 Kilowatt biomass gasification plant should be eligible to apply for a renewable energy cash back incentive program offered by the U.S. Federal Government. If it concludes its planned investment in Phoenix Energy, under Section 1603 of the American Reinvestment and Recovery Act, Cleantech Transit will be entitled to receive its pro-rata share of 30% cash grant payments. Once the final interconnect process and application are complete the grant should be received within 60 days.

Read more at: